Geron GERN
NASDAQ GERN
$1.52 -0.03 (-1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Geron (GERN) Other financing activities (2019 - 2026)

Geron (GERN) posted Other financing activities of $914000.0 for Q1 2026, up 165.8% sequentially from -$1.4 million in Q4 2025.

Geron (GERN) Other financing activities (2019 - 2026) Analysis & Trends

Geron has reported Other financing activities for 8 years, with the latest figure at $914000.0 in Q1 2026.

  • Quarterly Other financing activities changed N/A year-over-year to $914000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $914000.0 (down 99.27% YoY) and the FY2024 annual result came in at $125.0 million, up 856.24% from the prior year.
  • Other financing activities improved to $914000.0 in Q1 2026 per GERN's latest filing, from -$1.4 million in the prior quarter.
  • Over five years, Other financing activities peaked at $124.6 million in Q4 2024 and troughed at -$92.8 million in Q4 2023.
  • A 5-year average of $10.2 million and a median of $694500.0 in 2025 frame the typical range for Other financing activities.
  • The sharpest annual moves came in 2023 and 2025: Other financing activities sank 41732.29% in 2023, then jumped 22125.0% in 2025.
  • Over 5 years, Other financing activities stood at $223000.0 in 2022, then tumbled by 41732.29% to -$92.8 million in 2023, then soared by 234.25% to $124.6 million in 2024, then slumped by 101.11% to -$1.4 million in 2025, then soared by 165.8% to $914000.0 in 2026.
  • According to Business Quant data, Other financing activities over the past three periods registered $914000.0, -$1.4 million, and $889000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Geron 1.02 Mn -299.83 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 473,000.00
Jun 30, 2026 473,000.00
Mar 31, 2026 914,000.00
Mar 31, 2026 914,000.00
Dec 31, 2025 -1.39 Mn
Dec 31, 2025 -1.39 Mn
Sep 30, 2025 889,000.00
Sep 30, 2025 889,000.00
Jun 30, 2025 500,000.00
Jun 30, 2025 500,000.00
Dec 31, 2024 124.63 Mn
Dec 31, 2024 124.63 Mn
Sep 30, 2024 4,000.00
Sep 30, 2024 4,000.00
Jun 30, 2024 365,000.00
Jun 30, 2024 365,000.00
Mar 31, 2024 49,000.00
Mar 31, 2024 49,000.00
Dec 31, 2023 -92.84 Mn
Dec 31, 2023 -92.84 Mn